1. Commissioned report › Research › Not peer-reviewed
2. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Docetaxel (Taxotere) for locally advanced squamous cell carcinoma of the head and neck.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

   Research output: Book/Report › Commissioned report

3. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Emtricitabine/tenofovir DF (Truvada)

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

   Research output: Book/Report › Commissioned report

4. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Epoetin delta (Dynepo)

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

   Research output: Book/Report › Commissioned report

5. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Fondaparinux Sodium (Arixtra®) for STEMI.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

   Research output: Book/Report › Commissioned report

6. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Fondaparinux Sodium (Arixtra®) for UA/NSTEMI.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

   Research output: Book/Report › Commissioned report

7. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Icatibant (Firazyr) for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1-esterase-inhibitor deficiency).

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

   Research output: Book/Report › Commissioned report

8. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

   Research output: Book/Report › Commissioned report

9. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Maraviroc (Celsentri) for treatment-experienced adults infected only with CCR5-tropic HIV-1.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.

   Research output: Book/Report › Commissioned report

10. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Pegfilgrastim (Neulasta) for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

11. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Raltegravir (Isentress) in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in treatment-experienced adult patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

12. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Rufinamide (Inovelon) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS).

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

13. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Stiripentol (Diacomit) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

14. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.

    Research output: Book/Report › Commissioned report

15. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Tenofovir disoproxil fumarate (Viread) for the treatment of hepatitis B.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

16. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Teriparatide (Forsteo) for the treatment of osteoporosis in men at increased risk of fracture.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

17. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Topotecan (Hycamtin®) for Small Cell Lung Carcinoma.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

18. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Trabectedin (Yondelis) for advanced soft tissue sarcoma.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

19. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

20. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Clofarabine (Evoltra)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

21. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Co-careldopa intestinal gel (Duodopa).

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

22. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Darunavir (Prezista)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

23. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Chronic, accelerated or blast phase CML.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

24. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

25. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Dexrazoxane (Savene)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

26. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Emtricitabine (Emtriva)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

27. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Idursulfase (Elaprase)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

28. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Parathyroid hormone (Preotact)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

29. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Tipranavir (Aptivus).

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

30. Published

    All Wales Medicines Strategy Group Final Assessment Report – Agalsidase alfa (Replagal)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

31. Published

    All-optical wavelength conversion.

    Tang, J., Fice, M., Khand, K. & Tang, J. M., 1 Jan 2001, 2001 ed. Unknown.

    Research output: Book/Report › Commissioned report

32. Published

    Amenability of radial permeability of Sitka spruce (Picea sitchensis (Bong.) Carr.) as affected by aspects of cell ends in uniseriate ray parenchyma tissue.

    Usta, I. & Hale, M. D., 1 Jan 2003, 2003 ed. Unknown.

    Research output: Book/Report › Commissioned report

33. Published

    American Minimalism in Europe during the 1970s

    ap Sion, P. E., 4 Dec 2015, Unknown Publisher.

    Research output: Book/Report › Commissioned report

34. Published

    An Evaluation of the Agencies Domestic Abuse Perpetrator Tasking (ADAPT) Programme in North Wales

    Loftus, B. & Hodgkinson, C., 1 Jun 2023, 38 p.

    Research output: Book/Report › Commissioned report

35. Published

    An Evaluation of the IPS Programme: I CAN Work

    Williams, S., Prendergast, L., Roberts, S., Burton, C. & Hartfiel, N., 2021, Bangor University. 88 p.

    Research output: Book/Report › Commissioned report

36. Published

    An analysis of the response to the Storm Emma-Holyhead Marina incident in March 2018: The release of marine litter after the storm and the resulting increased risk of spread of the colonial sea-squirt, Didemnum vexillum

    Whitehead, J., Wyn, G., Griffith, K. & Moore, A., 2019, Natural Resources Wales. (NRW Evidence Report; no. 366)

    Research output: Book/Report › Commissioned report

37. Published

    An evaluation of the Women’s Turnaround Service in North Wales

    Plows, A. J., Feilzer, M. Y. & Plows, A., 1 Jun 2012, Unknown Publisher.

    Research output: Book/Report › Commissioned report

38. Published

    An exploratory study of the perception of experienced community learning disability nurses of their roles and ways of working.

    Boarder, J. H., 1 Jan 2001, 2001 ed. Unknown.

    Research output: Book/Report › Commissioned report

39. Published

    An overview of the multi-agency response to child sexual exploitation in Peterborough

    Davies, C. T., Jun 2016, 32 p.

    Research output: Book/Report › Commissioned report

40. Published

    Analysis of Hospital Episode Statistics for Children and Young People aged 0-19 Years in England and Scotland.

    Noyes, J., Chaplin, S. & Place, M., 1 Jan 2002, 2002 ed. Unknown.

    Research output: Book/Report › Commissioned report

41. Published

    Analysis of Local Authority Area Plans

    Vinnicombe, S. & Noyes, J., Jan 2019, National Centre for Population Health and Wellbeing Research. 16 p.

    Research output: Book/Report › Commissioned report

42. Published

    Analysis of milk composition results.

    Ap Dewi, I., 1 Jan 2002, 2002 ed. Unknown.

    Research output: Book/Report › Commissioned report

43. Published

    Analysis of optical phase mismatch between counter propagating conjugate waves in four-wave mixing loop configurations

    Tang, J. & Tang, J. M., 1 Jan 2001, 2001 ed. Unknown.

    Research output: Book/Report › Commissioned report

44. Published

    Analysis of short and long-term trends in temperature and salinity in the Menai Strait.

    Evans, G. L. & Mitchelson-Jacob, E. G., 1 Jan 2001, 2001 ed. Unknown.

    Research output: Book/Report › Commissioned report

45. Published

    Analysis of the Potential Economic Impact of Guidance of Improving Outcomes for People with Brain and other CNS Tumours

    Linck, P. G., Linck, P., Priedane, E., Hughes, D. A. & Edwards, R. T., 1 Jan 2006, 2006 ed. Unknown.

    Research output: Book/Report › Commissioned report

46. Published

    Analysis of the Potential Economic Impact of Guidance of improving Outcomes for Children and Young People with Cancer

    Linck, P., Tunnage, B., Hughes, D. A. & Edwards, R. T., 1 Jan 2005, 2005 ed. Unknown.

    Research output: Book/Report › Commissioned report

47. Published

    Analysis of the Potential Economic Impact of Guidance of improving Outcomes for Patients with Sarcoma

    Linck, P., Hughes, D. A. & Edwards, R. T., 1 Jan 2006, 2006 ed. Unknown.

    Research output: Book/Report › Commissioned report

48. Published

    Analysis of the Potential Economic Impact of Guidance of improving Outcomes for Patients with Skin Cancer

    Linck, P., Hughes, D. A. & Edwards, R. T., 1 Jan 2006, 2006 ed. Unknown.

    Research output: Book/Report › Commissioned report

49. Published

    Analysis of the viability of “land sparing” and “land sharing” strategies for commercial woodland expansion within Wales

    Wiik, E., Pagella, T., Healey, J., Stephen, B., McKay, H. & Jenkins, T., 31 Mar 2020, Bangor: Bangor University.

    Research output: Book/Report › Commissioned report

50. Published

    Anti-Shi'ism in Pakistan: Commissioned Report

    Wali, F., 15 Jun 2018, instructed on behalf of Immigration Advice Service. 12 p.

    Research output: Book/Report › Commissioned report

51. Published

    Apostasy in Pakistan: Treatment of Atheists in Pakistan: Commisioned Report

    Wali, F., 19 Jan 2018, 14 p.

    Research output: Book/Report › Commissioned report